Global Contrast Agents 麻豆原创 Growth 2025-2031

Publication ID:

LPI07251326

Publication Date:

July 1, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Contrast Agents market size is predicted to grow from US$ 6338 million in 2025 to US$ 9430 million in 2031; it is expected to grow at a CAGR of 6.8% from 2025 to 2031.
Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.
Global Contrast Agents key players include GE Healthcare, Bayer, Bracco Imaging, Guerbet Group, etc. Global top four manufacturers hold a share over 75%.
Asia-Pacific is the largest market, with a share over 40%, followed by Europe, and North America, both have a share over 50 percent.
In terms of product, X-ray and CT is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospitals, followed by Clinics.
The 鈥淐ontrast Agents Industry Forecast鈥� looks at past sales and reviews total world Contrast Agents sales in 2024, providing a comprehensive analysis by region and market sector of projected Contrast Agents sales for 2025 through 2031. With Contrast Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contrast Agents industry.
This Insight Report provides a comprehensive analysis of the global Contrast Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contrast Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Contrast Agents market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contrast Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contrast Agents.
This report presents a comprehensive overview, market shares, and growth opportunities of Contrast Agents market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
X-ray and CT
MRI
Ultrasound
Segmentation by Application:
Hospitals
Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Hengrui Medicine
Lantheus
YRPG
BeiLu Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contrast Agents market?
What factors are driving Contrast Agents market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contrast Agents market opportunities vary by end market size?
How does Contrast Agents break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Contrast Agents Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Contrast Agents by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Contrast Agents by Country/Region, 2020, 2024 & 2031
2.2 Contrast Agents Segment by Type
2.2.1 X-ray and CT
2.2.2 MRI
2.2.3 Ultrasound
2.3 Contrast Agents Sales by Type
2.3.1 Global Contrast Agents Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Contrast Agents Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Contrast Agents Sale Price by Type (2020-2025)
2.4 Contrast Agents Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.5 Contrast Agents Sales by Application
2.5.1 Global Contrast Agents Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Contrast Agents Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Contrast Agents Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Contrast Agents Breakdown Data by Company
3.1.1 Global Contrast Agents Annual Sales by Company (2020-2025)
3.1.2 Global Contrast Agents Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Contrast Agents Annual Revenue by Company (2020-2025)
3.2.1 Global Contrast Agents Revenue by Company (2020-2025)
3.2.2 Global Contrast Agents Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Contrast Agents Sale Price by Company
3.4 Key Manufacturers Contrast Agents Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contrast Agents Product Location Distribution
3.4.2 Players Contrast Agents Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Contrast Agents by Geographic Region
4.1 World Historic Contrast Agents 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Contrast Agents Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Contrast Agents Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Contrast Agents 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Contrast Agents Annual Sales by Country/Region (2020-2025)
4.2.2 Global Contrast Agents Annual Revenue by Country/Region (2020-2025)
4.3 Americas Contrast Agents Sales Growth
4.4 APAC Contrast Agents Sales Growth
4.5 Europe Contrast Agents Sales Growth
4.6 Middle East & Africa Contrast Agents Sales Growth
5 Americas
5.1 Americas Contrast Agents Sales by Country
5.1.1 Americas Contrast Agents Sales by Country (2020-2025)
5.1.2 Americas Contrast Agents Revenue by Country (2020-2025)
5.2 Americas Contrast Agents Sales by Type (2020-2025)
5.3 Americas Contrast Agents Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contrast Agents Sales by Region
6.1.1 APAC Contrast Agents Sales by Region (2020-2025)
6.1.2 APAC Contrast Agents Revenue by Region (2020-2025)
6.2 APAC Contrast Agents Sales by Type (2020-2025)
6.3 APAC Contrast Agents Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Contrast Agents by Country
7.1.1 Europe Contrast Agents Sales by Country (2020-2025)
7.1.2 Europe Contrast Agents Revenue by Country (2020-2025)
7.2 Europe Contrast Agents Sales by Type (2020-2025)
7.3 Europe Contrast Agents Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Contrast Agents by Country
8.1.1 Middle East & Africa Contrast Agents Sales by Country (2020-2025)
8.1.2 Middle East & Africa Contrast Agents Revenue by Country (2020-2025)
8.2 Middle East & Africa Contrast Agents Sales by Type (2020-2025)
8.3 Middle East & Africa Contrast Agents Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contrast Agents
10.3 Manufacturing Process Analysis of Contrast Agents
10.4 Industry Chain Structure of Contrast Agents
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contrast Agents Distributors
11.3 Contrast Agents Customer
12 World Forecast Review for Contrast Agents by Geographic Region
12.1 Global Contrast Agents 麻豆原创 Size Forecast by Region
12.1.1 Global Contrast Agents Forecast by Region (2026-2031)
12.1.2 Global Contrast Agents Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Contrast Agents Forecast by Type (2026-2031)
12.7 Global Contrast Agents Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 GE Healthcare
13.1.1 GE Healthcare Company Information
13.1.2 GE Healthcare Contrast Agents Product Portfolios and Specifications
13.1.3 GE Healthcare Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 GE Healthcare Main Business Overview
13.1.5 GE Healthcare Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Contrast Agents Product Portfolios and Specifications
13.2.3 Bayer Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Bracco Imaging
13.3.1 Bracco Imaging Company Information
13.3.2 Bracco Imaging Contrast Agents Product Portfolios and Specifications
13.3.3 Bracco Imaging Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Bracco Imaging Main Business Overview
13.3.5 Bracco Imaging Latest Developments
13.4 Guerbet Group
13.4.1 Guerbet Group Company Information
13.4.2 Guerbet Group Contrast Agents Product Portfolios and Specifications
13.4.3 Guerbet Group Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Guerbet Group Main Business Overview
13.4.5 Guerbet Group Latest Developments
13.5 Hengrui Medicine
13.5.1 Hengrui Medicine Company Information
13.5.2 Hengrui Medicine Contrast Agents Product Portfolios and Specifications
13.5.3 Hengrui Medicine Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Hengrui Medicine Main Business Overview
13.5.5 Hengrui Medicine Latest Developments
13.6 Lantheus
13.6.1 Lantheus Company Information
13.6.2 Lantheus Contrast Agents Product Portfolios and Specifications
13.6.3 Lantheus Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Lantheus Main Business Overview
13.6.5 Lantheus Latest Developments
13.7 YRPG
13.7.1 YRPG Company Information
13.7.2 YRPG Contrast Agents Product Portfolios and Specifications
13.7.3 YRPG Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 YRPG Main Business Overview
13.7.5 YRPG Latest Developments
13.8 BeiLu Pharma
13.8.1 BeiLu Pharma Company Information
13.8.2 BeiLu Pharma Contrast Agents Product Portfolios and Specifications
13.8.3 BeiLu Pharma Contrast Agents Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 BeiLu Pharma Main Business Overview
13.8.5 BeiLu Pharma Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.